Valeria Ricotti
Overview
Explore the profile of Valeria Ricotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dystrophin isoform deficiency and upper-limb and respiratory function in Duchenne muscular dystrophy
Chesshyre M, Ridout D, Stimpson G, Ricotti V, De Lucia S, Niks E, et al.
Dev Med Child Neurol
. 2025 Mar;
PMID: 40084496
Aim: To investigate the associations between mutations expected to differentially affect Dp140 expression and long-term trajectories of respiratory and upper-limb motor outcomes in Duchenne muscular dystrophy (DMD). Method: In a...
2.
Boehler J, Brown K, Ricotti V, Morris C
Skelet Muscle
. 2024 Jan;
14(1):2.
PMID: 38229112
Background: Multiple clinical trials to assess the efficacy of AAV-directed gene transfer in participants with Duchenne muscular dystrophy (DMD) are ongoing. The success of these trials currently relies on standard...
3.
Ayyar Gupta V, Pitchforth J, Domingos J, Ridout D, Iodice M, Rye C, et al.
PLoS One
. 2023 Apr;
18(4):e0283669.
PMID: 37099511
The North Star ambulatory assessment (NSAA) is a functional motor outcome measure in Duchenne muscular dystrophy (DMD), widely used in clinical trials and natural history studies, as well as in...
4.
van de Velde N, Koeks Z, Signorelli M, Verwey N, Overzier M, Bakker J, et al.
Neurology
. 2023 Feb;
100(9):e975-e984.
PMID: 36849458
Background And Objectives: The slow and variable disease progression of Becker muscular dystrophy (BMD) urges the development of biomarkers to facilitate clinical trials. We explored changes in 3 muscle-enriched biomarkers...
5.
Ricotti V, Kadirvelu B, Selby V, Festenstein R, Mercuri E, Voit T, et al.
Nat Med
. 2023 Jan;
29(1):95-103.
PMID: 36658421
Artificial intelligence has the potential to revolutionize healthcare, yet clinical trials in neurological diseases continue to rely on subjective, semiquantitative and motivation-dependent endpoints for drug development. To overcome this limitation,...
6.
Kadirvelu B, Gavriel C, Nageshwaran S, Chan J, Nethisinghe S, Athanasopoulos S, et al.
Nat Med
. 2023 Jan;
29(1):86-94.
PMID: 36658420
Friedreich's ataxia (FA) is caused by a variant of the Frataxin (FXN) gene, leading to its downregulation and progressively impaired cardiac and neurological function. Current gold-standard clinical scales use simplistic...
7.
Anthony K, Ala P, Catapano F, Meng J, Domingos J, Perry M, et al.
Hum Gene Ther
. 2022 Dec;
34(9-10):439-448.
PMID: 36453228
Duchenne muscular dystrophy (DMD) is caused by the lack of dystrophin, but many patients have rare revertant fibers that express dystrophin. The skeletal muscle pathology of DMD patients includes immune...
8.
Chesshyre M, Ridout D, Hashimoto Y, Ookubo Y, Torelli S, Maresh K, et al.
J Cachexia Sarcopenia Muscle
. 2022 Jan;
13(2):1360-1372.
PMID: 35083887
Background: Duchenne muscular dystrophy (DMD) is caused by DMD mutations leading to dystrophin loss. Full-length Dp427 is the primary dystrophin isoform expressed in muscle and is also expressed in the...
9.
Trucco F, Ridout D, Domingos J, Maresh K, Chesshyre M, Munot P, et al.
Muscle Nerve
. 2021 Oct;
65(1):67-74.
PMID: 34606104
Introduction/aims: Mutations amenable to skipping of specific exons have been associated with different motor progression in Duchenne muscular dystrophy (DMD). Less is known about their association with long-term respiratory function....
10.
Coratti G, Pane M, Brogna C, Ricotti V, Messina S, DAmico A, et al.
PLoS One
. 2021 Jun;
16(6):e0253882.
PMID: 34170974
Introduction: The aim of this study was to report 36-month longitudinal changes using the North Star Ambulatory Assessment (NSAA) in ambulant patients affected by Duchenne muscular dystrophy amenable to skip...